BEIJING, March 15, 2012 /PRNewswire-Asia-FirstCall/
-- Dehaier Medical Systems Ltd. (NASDAQ: DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that the Company plans
to release its financial results for the fourth quarter and full
year of 2011 ended December 31, 2011 on Monday,
March 19, 2012, after the stock market closes.
(Logo:
http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)
Company management will host a conference call for investors in
the following morning on Tuesday, March 20,
2012 at 8:30 a.m. EST.
Interested parties may access the call by dialing:
Live Participant Dial In
(Toll Free):
|
877-407-8033
|
Live Participant Dial In
(International – Country Code - 001):
|
201-689-8033
|
For those unable to participate, the call will be available as a
live, listen-only webcast on the Company's website at
http://www.dehaier.com.cn/IR/index.html or by clicking the
following link:
http://www.investorcalendar.com/IC/CEPage.asp?ID=167810
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent
Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents and five software
copyrights; additionally Dehaier has two pending software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's membership in the
Zhongguancun Association and the meaning of and retention of any
ratings granted to Dehaier (including any factors affecting such
ratings). These statements are subject to uncertainties and risks
including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the United States Securities and Exchange
Commission. All such forward-looking statements, whether written or
oral, and whether made by or on behalf of the company, are
expressly qualified by the cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com
In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com
SOURCE Dehaier Medical Systems Ltd.